Stock Events

Co-Diagnostics 

€0.96
2
+€0+0% Today

Statistics

Day High
0.96
Day Low
0.96
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
32.65M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

9MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.5
-0.35
-0.19
-0.04
Expected EPS
-0.21
Actual EPS
-0.31

People Also Follow

This list is based on the watchlists of people on Stock Events who follow C97.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap9.98B
QIAGEN offers diagnostic solutions, including molecular diagnostics which directly compete with Co-Diagnostics' testing technologies.
Thermo Fisher Scientific
TMO
Mkt Cap222.94B
Thermo Fisher Scientific provides a broad range of diagnostic and research products, including molecular diagnostics that compete with CODX offerings.
Bio-Rad Laboratories
BIO
Mkt Cap8.16B
Bio-Rad Laboratories offers a variety of diagnostic tests and systems, including PCR-based tests, which are in direct competition with Co-Diagnostics' products.
Hologic
HOLX
Mkt Cap17.22B
Hologic specializes in diagnostics for women's health, including molecular diagnostics, competing in some of the same spaces as Co-Diagnostics.
Quest Diagnostics
DGX
Mkt Cap15.7B
Quest Diagnostics provides diagnostic testing services, including molecular diagnostics, competing with Co-Diagnostics in the laboratory testing market.
Labcorp
LH
Mkt Cap0
Laboratory Corporation of America offers a wide range of diagnostic tests, including molecular diagnostics, making it a competitor in the diagnostics market.
Abbott Laboratories
ABT
Mkt Cap180.83B
Abbott Laboratories offers a broad portfolio of diagnostic products, including molecular diagnostics, competing across several of Co-Diagnostics' market segments.
Agilent Technologies
A
Mkt Cap44.15B
Agilent Technologies provides life sciences, diagnostics, and applied chemical markets with instruments and services, including diagnostics that compete with Co-Diagnostics.
Baxter International
BAX
Mkt Cap17.27B
Baxter International offers a range of medical devices and laboratory equipment, some of which are used in diagnostic applications that compete with Co-Diagnostics.
Roche
RHHBY
Mkt Cap177.61B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including molecular diagnostics, making it a significant competitor to Co-Diagnostics in the global diagnostics market.

About

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
Employees
39
Country
US
ISIN
US1897631057
WKN
000A2DU6V

Listings